239 related articles for article (PubMed ID: 29891043)
1. Erythropoietin Enhances Bone Repair Effects via the Hypoxia-Inducible Factor Signal Pathway in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.
Li D; Hu Q; Tan G; Xie X; Yang Z; Kang P
Am J Med Sci; 2018 Jun; 355(6):597-606. PubMed ID: 29891043
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bone defect repairing effects in glucocorticoid-induced osteonecrosis of the femoral head using a porous nano-lithium-hydroxyapatite/gelatin microsphere/erythropoietin composite scaffold.
Li D; Xie X; Yang Z; Wang C; Wei Z; Kang P
Biomater Sci; 2018 Feb; 6(3):519-537. PubMed ID: 29369309
[TBL] [Abstract][Full Text] [Related]
3. Porous, lithium-doped calcium polyphosphate composite scaffolds containing vascular endothelial growth factor (VEGF)-loaded gelatin microspheres for treating glucocorticoid-induced osteonecrosis of the femoral head.
Luo Y; Li D; Xie X; Kang P
Biomed Mater; 2019 Apr; 14(3):035013. PubMed ID: 30802884
[TBL] [Abstract][Full Text] [Related]
4. The effect of deferoxamine on angiogenesis and bone repair in steroid-induced osteonecrosis of rabbit femoral heads.
Li J; Fan L; Yu Z; Dang X; Wang K
Exp Biol Med (Maywood); 2015 Feb; 240(2):273-80. PubMed ID: 25294892
[TBL] [Abstract][Full Text] [Related]
5. Desferoxamine protects against glucocorticoid-induced osteonecrosis of the femoral head via activating HIF-1α expression.
Jing X; Du T; Yang X; Zhang W; Wang G; Liu X; Li T; Jiang Z
J Cell Physiol; 2020 Dec; 235(12):9864-9875. PubMed ID: 32437020
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Enhanced Bone Regeneration Through the HIF-1α/β-Catenin Pathway in Femoral Head Osteonecrosis.
Zhao H; Yeersheng R; Xia Y; Kang P; Wang W
Am J Med Sci; 2021 Jul; 362(1):78-91. PubMed ID: 33727018
[TBL] [Abstract][Full Text] [Related]
7. Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats.
Chen S; Li J; Peng H; Zhou J; Fang H
Int J Mol Med; 2014 Apr; 33(4):840-8. PubMed ID: 24503957
[TBL] [Abstract][Full Text] [Related]
8. The Pathophysiological Sequence of Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Male Mice.
Weinstein RS; Hogan EA; Borrelli MJ; Liachenko S; O'Brien CA; Manolagas SC
Endocrinology; 2017 Nov; 158(11):3817-3831. PubMed ID: 28938402
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis.
Zhang C; Yang F; Cornelia R; Tang W; Swisher S; Kim H
Bone; 2011 Mar; 48(3):507-13. PubMed ID: 20950722
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K2 Prevents Glucocorticoid-induced Osteonecrosis of the Femoral Head in Rats.
Zhang YL; Yin JH; Ding H; Zhang W; Zhang CQ; Gao YS
Int J Biol Sci; 2016; 12(4):347-58. PubMed ID: 27019620
[TBL] [Abstract][Full Text] [Related]
11. Administration of erythropoietin prevents bone loss in osteonecrosis of the femoral head in mice.
Xu T; Jin H; Lao Y; Wang P; Zhang S; Ruan H; Mao Q; Zhou L; Xiao L; Tong P; Wu C
Mol Med Rep; 2017 Dec; 16(6):8755-8762. PubMed ID: 29039481
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Mesenchymal Stem Cells Overexpressing HIF-1α Prevented the Progression of Glucocorticoid-Induced Avascular Osteonecrosis of Femoral Heads in Mice.
Zhang XX; Liang X; Li SR; Guo KJ; Li DF; Li TF
Cell Transplant; 2022; 31():9636897221082687. PubMed ID: 35287482
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α transgenic bone marrow cells can promote tissue repair in cases of corticosteroid-induced osteonecrosis of the femoral head in rabbits.
Ding H; Gao YS; Hu C; Wang Y; Wang CG; Yin JM; Sun Y; Zhang CQ
PLoS One; 2013; 8(5):e63628. PubMed ID: 23675495
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro characteristic of HIF-1α and relative genes in ischemic femoral head necrosis.
Zhang W; Yuan Z; Pei X; Ma R
Int J Clin Exp Pathol; 2015; 8(6):7210-6. PubMed ID: 26261616
[TBL] [Abstract][Full Text] [Related]
15. SIRT6 Prevents Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats.
Fang L; Zhang G; Wu Y; Li Z; Gao S; Zhou L
Oxid Med Cell Longev; 2022; 2022():6360133. PubMed ID: 36275897
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.
Varoga D; Drescher W; Pufe M; Groth G; Pufe T
Clin Orthop Relat Res; 2009 Dec; 467(12):3273-82. PubMed ID: 19763724
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental osteonecrosis of the hip in adult rabbits with a single local injection of recombinant human FGF-2 microspheres.
Kuroda Y; Akiyama H; Kawanabe K; Tabata Y; Nakamura T
J Bone Miner Metab; 2010 Nov; 28(6):608-16. PubMed ID: 20354742
[TBL] [Abstract][Full Text] [Related]
18. Administration of necrostatin-1 ameliorates glucocorticoid-induced osteonecrosis of the femoral head in rats.
Feng M; Zhang R; Zhang M; Chen M; Ji L; Duan D; Qiang H
J Mol Histol; 2023 Jun; 54(3):207-216. PubMed ID: 37156987
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head.
Kim HK; Bian H; Aya-ay J; Garces A; Morgan EF; Gilbert SR
Bone; 2009 Aug; 45(2):280-8. PubMed ID: 19345751
[TBL] [Abstract][Full Text] [Related]
20. Lithium prevents glucocorticoid-induced osteonecrosis of the femoral head by regulating autophagy.
Wang Q; Yang Z; Li Q; Zhang W; Kang P
J Cell Mol Med; 2024 May; 28(10):e18385. PubMed ID: 38801405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
